CTMX
CytomX Therapeutics Inc.
$3.39
+$0.02(+0.74%)
74
Overall
80
Value
100
Tech
42
Quality
Market Cap
$326.53M
Volume
1.37M
52W Range
$0.40 - $3.49
Target Price
$5.79
EPS Estimates Overview
| Current Quarter | $-0.04 | Next Quarter | $-0.04 |
| Current Year | $0.05 | Next Year | $-0.29 |
| QoQ Growth | +0.0% | YoY Growth | -680.0% |
| 3Y EPS CAGR | +31.9% | Target Price | $5.79 |
| Consensus | Buy | Upside | +71.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTMX | $3.39 | +0.7% | 1.37M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get CytomX Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW